Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (1)
  • 2023 (2)
  • 2022 (4)
  • 2021 (2)
  • 2020 (1)

Subject

  • Drug Trafficking (118)
  • Arrests/Convictions - Major (83)
  • Synthetic drugs (74)
  • Seizures (Drugs/Property) (44)
  • Guns/Weapons (43)
  • Fake Pills (34)
  • Major Law Enforcement Operation (23)
  • Guilty Plea (21)
  • OCDETF/Task Force (14)
  • Prescription Drugs (14)
  • Overdose (13)
  • Take Back Day (13)
  • Outreach/Drug Prevention (12)
  • Diversion Division (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Extraditions (5)
  • Fentanyl Awareness (4)
  • Gangs (4)
  • Money Laundering (4)
  • Press Conferences (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Task Forces/Task Force Officers (4)
  • Counterfeit Pills (3)
  • International/Foreign Operations (3)
  • HIDTA (2)
  • One Pill Can Kill (2)
  • Dark Web- Internet Trafficking (1)
  • El Paso Intelligence Center (1)
  • Narcoterrorism (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Red Ribbon (1)
  • Scam Calls (1)
  • Pharmaceuticals/Pharmacists/Physicians (10)
  • Asset Forfeiture (1)

Drug Name

  • Fentanyl (2)
  • Hydromorphone (1)
  • Methamphetamine (1)
  • Morphine (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (39)
  • St. Louis (33)
  • Chicago (28)
  • New York (21)
  • Miami (18)
  • Atlanta (12)
  • New Jersey (11)
  • Seattle (9)
  • Sede (9)
  • Dallas (8)
  • New Orleans (8)
  • Houston (7)
  • San Francisco (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • Rocky Mountain (4)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • El Paso (11)
Clear All Results
11 Results - Showing 1 to 10
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
PRESS RELEASE

Drug Enforcement Administration Announces Fall Take Back Day

El Paso, Texas – On Saturday October 28, from 10 a.m. to 2 p.m., the Drug Enforcement Administration and various local agencies will host DEA’s National Prescription Drug Take Back Day at locations across the country. DEA and its partners will collect tablets, capsules, patches, and other solid forms of...
PRESS RELEASE

DEA Operation Last Mile Tracks Down Sinaloa and Jalisco Cartel Associates Operating within the United States

El Paso, Texas – On Friday, the U.S. Drug Enforcement Administration announced the results of a year-long national operation, “Operation Last Mile,” targeting operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels responsible for the last mile of fentanyl and methamphetamine distribution on our streets and on social...
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...
PRESS RELEASE

Las Cruces psychiatrist pleads guilty to unlawfully prescribing opioids

ALBUQUERQUE, N.M. – Mark Beale, 75, of Las Cruces, New Mexico, pleaded guilty on March 25 in federal court to unlawful dispensing and distributing of a schedule II controlled substance. Beale will remain on conditions of release pending sentencing. A federal grand jury indicted Beale on June 23, 2021. According...
PRESS RELEASE

Ready Pharmacy agrees to $400,000 settlement relating to Controlled Substances Act claims

ALBUQERQUE, N.M. – Fred J. Federici, U.S. Attorney for the District of New Mexico, has announced that Ready Pharmacy has agreed to a $400,000 settlement relating to civil claims brought by the Department of Justice on behalf of the U.S. Drug Enforcement Administration’s (DEA) El Paso Division Regulatory Diversion Group...
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster